its relevance to retatrutide specifically is not yet established A history of pancreatitis or significant gastrointestinal disease Gallbladder disease , including a history of gallstones or cholecystitis Diabetes mellitus , particularly if managed with insulin or sulphonylureas, due to hypoglycaemia risk Cardiovascular disease , including arrhythmias or recent cardiac events Renal or hepatic impairment , which may affect tolerability and increase the risk of dehydration-related complications Pregnancy or breastfeeding no safety data exist for retatrutide in these groups Use of oral medicines where absorption may be affected by delayed gastric emptying , such as levothyroxine or combined oral contraceptives Seek urgent medical attention if you experience severe or persistent nausea or vomiting, persistent abdominal pain (which may indicate pancreatitis or gallbladder disease), signs of an allergic reaction (rash, swelling, difficulty breathing), chest pain, palpitations, or signs of dehydration

OTC oral supplements have varying bioavailability and come in different strengths, usually 500-2,000 mcg
At 2.5 mg/mL, 25 units = 0.625 mg
What's the difference between B12 shots and lipo B12 shots (MIC injections)
ME B12 Forte Injection 1ml is indicated for the treatment and maintenance therapy of conditions associated with or caused by Vitamin B12 deficiency